Close Menu

Benitec

Benitec Biopharma this week said that it is collaborating with Stanford University to test its expressed RNAi-based neuropathic pain treatment, called Nervarna, in vivo.

Researchers from the University of Western Ontario, in collaboration with Benitec Biopharma and stem cell firm Medistem, reported last month on the use of expressed RNAi technology to prolong the survival of an allogenic heart transplant by down-regulating certain genes involved

Irish biopharmaceutical firm Genable Technologies announced this week that it has acquired an exclusive, worldwide license to Benitec Biopharma's expressed RNAi technology for use in a treatment for the rare ocular disease rhodopsin-linked autosomal dominant retinitis pigmentosa.

Benitec Biopharma announced this week that a challenge to a key UK patent has been withdrawn, and that the amended claims in the patent have been accepted by the United Kingdom Intellectual Property Office.

Expressed RNAi drug developer Benitec Biopharma this week provided an update on its pipeline, stating that its two lead programs in cancer-associated neuropathic pain and drug-resistant lung cancer have fallen behind schedule as the company further optimizes its therapeutic candi

By Doug Macron
Benitec Biopharma last week broke out new details about its in-house pipeline, stating that it aims to have three drugs in clinical studies next year and possibly a fourth by 2014.

Benitec Biopharma said this week that it has non-exclusively licensed its expressed RNAi technology to Calimmune for use in developing an RNAi-based HIV/AIDS treatment.

Benitec Biopharma this week announced that it has collaborated with stem cell firm Medistem to treat rheumatoid arthritis in preclinical animal models using their respective technologies.

Title: Method for Determining Immunostimulatory Activity of RNA Oligonucleotides
Patent Number: 8,076,068
Filed: Sept. 14, 2006
Lead Inventor: Gunther Hartmann, University of Bonn

Pages

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.